{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:37:31Z","timestamp":1792229851052,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is a highly complex reproductive metabolic disorder and women with PCOS have high prevalence of non-alcoholic fatty liver disease (NAFLD). Despite both hyperandrogenism and insulin resistance are common pathophysiologies in NAFLD and PCOS, this association is still controversial. Therefore, the aim of this study is to evaluate the relationship between hyperandrogenism and NAFLD in females diagnosed with PCOS. We recruited 667 women diagnosed with PCOS and 289 women with regular menstrual cycles as control. The PCOS diagnosis was made using National Institute of Child Health and Human Disease criteria. Total and free testosterone levels (TT and TF, respectively), and free androgen index (FAI) were used as measures of hyperandrogenism. Fatty liver index and liver fat score (FLI and LFS, respectively), and hepatic steatosis index (HSI) were used to assess NAFLD. The prevalence of NAFLD in PCOS women evaluated by LFS, FLI, and HIS were 19.9, 10.3, and 32.2%, respectively. In the control group, the incidence was 2.1, 0.7, and 4.2%, respectively. Both FT and FAI levels showed significant association with increased NAFLD-related indices, after adjusting for insulin resistance and other factors (LFS (OR 3.18 (95% CI 1.53\u20136.63) in FT; 1.12 (1.04\u20131.22) in FAI), FLI (OR 2.68 (95% CI 1.43\u20135.03) in FT; 1.13 (1.06\u20131.20) in FAI), and HSI (OR 3.29 (95% CI 2.08\u20135.21) in FT; 1.5 (1.09\u20131.21) in FAI). TT did not exhibit association with any NAFLD index. In women with PCOS, significantly higher rate of NAFLD was observed compared to the control women. The FT and FAI were independently associated with NAFLD in women with PCOS. The findings suggest the possibility of hyperandrogenism contributing to the progression and\/or development of NAFLD in PCOS.<\/jats:p>","DOI":"10.1038\/s41598-023-39428-4","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:03:34Z","timestamp":1692255814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome"],"prefix":"10.1038","volume":"13","author":[{"given":"So-hyeon","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Ah","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Kyeong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyein","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungah","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"1","key":"39428_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41\u201347 (2004).","journal-title":"Hum. Reprod."},{"key":"39428_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","volume":"86","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis, P., Tarlatzis, B. C. & Kauffman, R. P. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86, 33\u201343 (2018).","journal-title":"Metabolism"},{"issue":"1","key":"39428_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016).","journal-title":"Hepatology"},{"issue":"12","key":"39428_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","volume":"40","author":"ALL Rocha","year":"2017","unstructured":"Rocha, A. L. L. et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Systematic review and meta-analysis. J. Endocrinol. Invest. 40(12), 1279\u20131288 (2017).","journal-title":"J. Endocrinol. Invest."},{"key":"39428_CR5","doi-asserted-by":"publisher","first-page":"105445","DOI":"10.1016\/j.jsbmb.2019.105445","volume":"194","author":"N Salva-Pastor","year":"2019","unstructured":"Salva-Pastor, N., Chavez-Tapia, N. C., Uribe, M. & Nuno-Lambarri, N. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. J. Steroid Biochem. Mol. Biol. 194, 105445 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"39428_CR6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1210\/jc.2018-01808","volume":"104","author":"KM Utzschneider","year":"2019","unstructured":"Utzschneider, K. M., Kahn, S. E. & Polidori, D. C. Hepatic insulin extraction in NAFLD is related to insulin resistance rather than liver fat content. J. Clin. Endocrinol. Metab. 104(5), 1855\u20131865 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"39428_CR7","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.2012-1382","volume":"97","author":"H Jones","year":"2012","unstructured":"Jones, H. et al. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 97(10), 3709\u20133716 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"39428_CR8","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran, B. et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med. 15(3), e1002542 (2018).","journal-title":"PLoS Med."},{"issue":"6","key":"39428_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/humrep\/dew076","volume":"31","author":"D Macut","year":"2016","unstructured":"Macut, D. et al. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Hum. Reprod. 31(6), 1347\u20131353 (2016).","journal-title":"Hum. Reprod."},{"issue":"11","key":"39428_CR10","doi-asserted-by":"publisher","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","volume":"12","author":"S Petta","year":"2017","unstructured":"Petta, S. et al. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. PLoS ONE 12(11), e0186136 (2017).","journal-title":"PLoS ONE"},{"issue":"3","key":"39428_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137(3), 865\u2013872 (2009).","journal-title":"Gastroenterology"},{"key":"39428_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"39428_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 42(7), 503\u2013508 (2010).","journal-title":"Dig Liver Dis."},{"key":"39428_CR14","unstructured":"Zawadzki, J. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. in Polycystic ovary syndrome. (ed. Dunaif, A.) 377\u2013384 (Blackwell Scientific, 1992)."},{"issue":"10","key":"39428_CR15","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen, A., Verdonck, L. & Kaufman, J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84(10), 3666\u20133672 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"39428_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale, H. F. et al. Epidemiology, diagnosis and management of hirsutism: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum. Reprod. Update 18(2), 146\u2013170 (2012).","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"39428_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cen.13380","volume":"87","author":"S Hong","year":"2017","unstructured":"Hong, S. et al. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome. Clin. Endocrinol. 87(4), 375\u2013380 (2017).","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"39428_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412\u2013419 (1985).","journal-title":"Diabetologia"},{"issue":"Pt 4","key":"39428_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/000456328902600402","volume":"26","author":"LF Blight","year":"1989","unstructured":"Blight, L. F., Judd, S. J. & White, G. H. Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism. Ann. Clin. Biochem. 26(Pt 4), 311\u2013316 (1989).","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"39428_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4254\/wjh.v12.i4.149","volume":"12","author":"L Lind","year":"2020","unstructured":"Lind, L. et al. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World J. Hepatol. 12(4), 149\u2013159 (2020).","journal-title":"World J. Hepatol."},{"issue":"9","key":"39428_CR21","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/jcm9092851","volume":"9","author":"TY Jung","year":"2020","unstructured":"Jung, T. Y., Kim, M. S., Hong, H. P., Kang, K. A. & Jun, D. W. Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting. J. Clin. Med. 9(9), 2851 (2020).","journal-title":"J. Clin. Med."},{"issue":"5","key":"39428_CR22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera, L., Fredich-Rust, M. & Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(5), 1264\u20131281 (2019).","journal-title":"Gastroenterology"},{"issue":"10","key":"39428_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","volume":"40","author":"L Fedchuk","year":"2014","unstructured":"Fedchuk, L. et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 40(10), 1209\u20131222 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"39428_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ijo.2017.116","volume":"41","author":"J Cai","year":"2017","unstructured":"Cai, J. et al. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. Int. J. Obes. 41(9), 1341\u20131347 (2017).","journal-title":"Int. J. Obes."},{"issue":"11","key":"39428_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/apt.14058","volume":"45","author":"JJ Kim","year":"2017","unstructured":"Kim, J. J. et al. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol. Ther. 45(11), 1403\u20131412 (2017).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"9","key":"39428_CR26","doi-asserted-by":"publisher","first-page":"e107584","DOI":"10.1371\/journal.pone.0107584","volume":"9","author":"Y-H Lee","year":"2014","unstructured":"Lee, Y.-H. et al. Non\u2013laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: Development, validation and comparison with other scores. PLoS ONE 9(9), e107584 (2014).","journal-title":"PLoS ONE"},{"issue":"2","key":"39428_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.clnu.2019.02.024","volume":"39","author":"N Motamed","year":"2020","unstructured":"Motamed, N. et al. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran. Clin. Nutr. 39(2), 468\u2013474 (2020).","journal-title":"Clin. Nutr."},{"key":"39428_CR28","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.diabet.2020.09.007","volume":"47","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women. Diabetes Metab. 47, 101199 (2020).","journal-title":"Diabetes Metab."},{"issue":"5","key":"39428_CR29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/jc.2018-00740","volume":"104","author":"C Saez-Lopez","year":"2019","unstructured":"Saez-Lopez, C. et al. Sex hormone-binding globulin expression correlates with acetyl-coenzyme A carboxylase and triglyceride content in human liver. J. Clin. Endocrinol. Metab. 104(5), 1500\u20131507 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"39428_CR30","doi-asserted-by":"publisher","first-page":"E2780","DOI":"10.1210\/jc.2014-2640","volume":"99","author":"SJ Winters","year":"2014","unstructured":"Winters, S. J. et al. Sex hormone-binding globulin gene expression and insulin resistance. J. Clin. Endocrinol. Metab. 99(12), E2780\u2013E2788 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"39428_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich, V., Sanguankeo, A., Riangwiwat, T. & Upala, S. Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Ann. Hepatol. 16(3), 382\u2013394 (2017).","journal-title":"Ann. Hepatol."},{"issue":"8","key":"39428_CR32","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2337\/db16-1147","volume":"66","author":"T Jelenik","year":"2017","unstructured":"Jelenik, T. et al. Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver. Diabetes 66(8), 2241\u20132253 (2017).","journal-title":"Diabetes"},{"issue":"7","key":"39428_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","volume":"142","author":"F Magkos","year":"2012","unstructured":"Magkos, F. et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 142(7), 1444\u20131446 (2012).","journal-title":"Gastroenterology"},{"issue":"6","key":"39428_CR34","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"Nelson, V. L., Legro, R. S., Strauss, J. F. III. & McAllister, J. M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 13(6), 946\u2013957 (1999).","journal-title":"Mol. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39428-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T17:16:58Z","timestamp":1700587018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39428-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39428-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"14 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13397"}}